Is it growing?
Is BCRX growing?
BioCryst Pharmaceuticals, Inc. has grown revenue 45% a year over three years and 64% a year over five.
+45%
Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · compounding fast · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +64%
Revenue growth, 5-year rate · +45% over three · growth has slowed since the five-year average
- Years of annual history on file
- 17
Years of annual history on file · FY2009 to FY2025, as filed
Details›
- Revenue FY2021
- $157M
- Revenue FY2022
- $271M
- Revenue FY2023
- $331M
- Revenue FY2024
- $451M
- Revenue FY2025
- $875M
Annual income statements as filed with the SEC.
Drug Manufacturers - Specialty & Generic
Ranks #2 of 28 by Smart Score